ERBB2 and breast cancer: After PPARγ was identified as a mature positive regulator of adipogenesis and lipid storage in 2013, inhibition of PPARγ was reported to reduce aldehyde dehydrogenase (ALDH) activity in ERBB2-positive breast cancer cells.